🇺🇸 Netromycin in United States

FDA authorised Netromycin on 28 February 1983

Marketing authorisations

FDA — authorised 28 February 1983

  • Status: approved

FDA — authorised 28 February 1983

  • Application: NDA050544
  • Marketing authorisation holder: SCHERING
  • Local brand name: NETROMYCIN
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

Netromycin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Metabolic approved in United States

Frequently asked questions

Is Netromycin approved in United States?

Yes. FDA authorised it on 28 February 1983; FDA authorised it on 28 February 1983.

Who is the marketing authorisation holder for Netromycin in United States?

Marketing authorisation holder not available in our data.